Condition
Crimean-Congo Hemorrhagic Fever clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Crimean-Congo Hemorrhagic Fever clinical trials that are recruiting, at sites in 2 countries (most in United States (1), Turkey (Türkiye) (1)). By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Adaptive Phase IIb Platform Trial to Test Therapies for Crimean-Congo Hemorrhagic Fever
A multi-arm, adaptive trial in adults with confirmed CCHF in Turkey and Iraq will test Favipiravir or Ribavirin against optimized standard care to see if these antivirals help clear the virus and improve outcomes.
-
Self-amplifying RNA vaccine for Crimean-Congo hemorrhagic fever in healthy adults
This will test whether different doses and a one- or two-dose schedule of the experimental HDT-321 vaccine are safe and trigger immune responses in healthy adults aged 18–64.
Quick answers
How many Crimean-Congo Hemorrhagic Fever clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), Turkey (Türkiye) (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.